Company intelligence / Profile preview

Dead Sea Medica

Netanya, Central District, Israeldeadseamedica.com ↗

Ownership: Private
Development stage: Commercial

Overview

Dead Sea Medica develops and markets patented natural solutions for water purification, algae control, and mosquito management using non-toxic materials derived from the Dead Sea region. Their Seleno-X flocculant technology is patented; BacStop addresses algae blooms; HD‑373 controls mosquito populations—all designed to be safe for humans, animals, fish, birds, and the environment

Therapeutic areas: OtherInfectious Diseases
Modalities: Natural product-based therapyDevice (water treatment systems)
Industry: Agriculture & AgTech

Drug pipeline

2 assets

Sele Cream Collagen+

Commercial

Indications: Anti-aging, Sun damage protection

1 more asset in the full pipeline.

Request access →

Partnerships

Not specified publicly.

Beyond the preview

Go deeper on Dead Sea Medica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dead Sea Medica.

Explore the full profile